Literature DB >> 10933460

Utility of Tc 99m HMPAO SPECT in the early diagnosis of Rasmussen's syndrome.

F Paladin1, G Capovilla, A Bonazza, R Mameli.   

Abstract

Neuroradiological examinations are important in the diagnosis of Rasmussen's syndrome (RS), but they frequently result normal in the early phase of the disease. We performed Tc 99m HMPAO SPECT (single photon emission computed tomography) on an 11-year, 5-month-old, right-handed girl, two months since the first seizure. SPECT showed a reduced uptake of HMPAO in the left temporal region despite normal results with magnetic resonance imaging (MRI). After six months, she developed epilepsia partialis continua, neurological signs appeared, and MRI showed cortical atrophy on the left side. SPECT seems to be a useful, inexpensive and diffuse technology able to give information in the early phases of RS useful in the prevention of serious consequences of the disease within a medical therapeutic program (ganciclovir or intravenous immunoglobulins).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10933460     DOI: 10.1007/bf02427604

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  10 in total

1.  Early detection of Rasmussen's syndrome by brain SPECT imaging.

Authors:  G J Burke; S A Fifer; J Yoder
Journal:  Clin Nucl Med       Date:  1992-09       Impact factor: 7.794

2.  Focal seizures due to chronic localized encephalitis.

Authors:  T RASMUSSEN; J OLSZEWSKI; D LLOYDSMITH
Journal:  Neurology       Date:  1958-06       Impact factor: 9.910

3.  Rasmussen's encephalitis: neuroimaging findings in four patients.

Authors:  R D Tien; B C Ashdown; D V Lewis; M R Atkins; P C Burger
Journal:  AJR Am J Roentgenol       Date:  1992-06       Impact factor: 3.959

4.  Treatment of Rasmussen's syndrome with ganciclovir.

Authors:  R S McLachlan; S Levin; W T Blume
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

5.  Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy.

Authors:  M A Farrell; M J DeRosa; J G Curran; D L Secor; M E Cornford; Y G Comair; W J Peacock; W D Shields; H V Vinters
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  Rasmussen's syndrome: longitudinal EEG study from the first seizure to epilepsia partialis continua.

Authors:  G Capovilla; F Paladin; B D Bernardina
Journal:  Epilepsia       Date:  1997-04       Impact factor: 5.864

7.  Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.

Authors:  S W Rogers; P I Andrews; L C Gahring; T Whisenand; K Cauley; B Crain; T E Hughes; S F Heinemann; J O McNamara
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

8.  Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients.

Authors:  Y M Hart; M Cortez; F Andermann; P Hwang; D R Fish; O Dulac; K Silver; N Fejerman; H Cross; A Sherwin
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

9.  Plasmapheresis in Rasmussen's encephalitis.

Authors:  P I Andrews; M A Dichter; S F Berkovic; M R Newton; J O McNamara
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

10.  Five patients with Rasmussen's syndrome investigated by single-photon-emission computed tomography.

Authors:  R English; N Soper; B J Shepstone; J M Hockaday; G Stores
Journal:  Nucl Med Commun       Date:  1989-01       Impact factor: 1.690

  10 in total
  2 in total

1.  Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis?

Authors:  L Chiapparini; T Granata; L Farina; E Ciceri; A Erbetta; F Ragona; E Freri; L Fusco; G Gobbi; G Capovilla; L Tassi; L Giordano; M Viri; B Dalla Bernardina; R Spreafico; M Savoiardo
Journal:  Neuroradiology       Date:  2003-02-12       Impact factor: 2.804

2.  Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics.

Authors:  Nicola Marchi; Tiziana Granata; Elena Freri; Emilio Ciusani; Francesca Ragona; Vikram Puvenna; Quingshan Teng; Andreas Alexopolous; Damir Janigro
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.